January 21, 2008
Prospector
Profile
117-06
 
Medical International Technology, Inc. NAICS 541711
1872 Beaulac, Ville Saint-Laurent Montreal, Quebec, Canada HR4 2E9 Description Biotechnology R&D
(514) 339-9355 Employees 0
http://www.mitcanada.ca/ Revenue (mil) 0.3380
  Income (mil) -0.8980
  Assets (mil) 0.6550
  Liability (mil) 0.6520
  (for the year ended 2007-09-30)
 
Category: Loss/Deficit
 
Event: Medical International Technology, Inc. had a net loss of $898,376 on revenues of $216,652 for the year ended September 30, 2007, much lower than the $1,509,633 net loss on $88,853 in revenues reported for the year ended September 30, 2006. The Company's balance sheet at September 30, 2007, showed an accumulated deficit of $6,971,531 and only $2,938 in stockholders' equity. It also has strained liquidity with $519,781 in total current assets available to pay $638,496 in total current liabilities.
 
Intellectual Property: The Company has obtained trademark registration in United States on the use of AGRO-JET (Reg. No. 2,712,089) and MED-JET (Reg. No. 2,798,613). [SEC Filing 10-KSB 12-21-07]
 
Description: Medical International Technology specializes in the research, development, marketing and sale of needle-free jet injector products designed for humans and animals, for single and mass injections.
 
Officers: Karim Menassa (Chair & Pres.); Michel Bayouk (Sec. & Dir.)
 
Auditor: PS Stephenson & Company PC
 
Securities: 27,058,663 common shares outstanding as of September 30, 2007.
 
 
 
return to main page